Applied Medical Seeks Injunction Against Medtronic
The legal move follows a jury ruling that Medtronic used anticompetitive tactics to sell advanced bipolar energy devices.
Updated on Oct. 5, 2026 in Healthcare
Live Poll
Should courts impose stricter penalties on companies found to have engaged in anticompetitive business practices?
Applied Medical Resources has filed a legal reply seeking a permanent injunction against Medtronic. The motion follows a jury verdict finding that Medtronic engaged in unlawful and anticompetitive conduct regarding the sale of advanced bipolar energy devices.
Why it matters
Operators in the medical device space should monitor this case as it directly challenges industry sales practices and potentially sets new standards for competitive conduct. Applied Medical asserts that Medtronic failed to provide adequate relief for its jury-confirmed anticompetitive behavior.
The filing highlights a benchmark relief period of two decades voluntarily provided by Ethicon in a prior matter. The court has yet to determine the final scope of the permanent injunction against Medtronic.
The players
Applied Medical Resources
A medical device manufacturer known for developing and producing advanced surgical technology products.
Medtronic
A global leader in medical technology that provides a broad range of surgical and healthcare devices.
Ethicon
A subsidiary of Johnson & Johnson specializing in surgical technology and medical devices.
The details
Applied Medical Resources submitted the reply to argue that Medtronic has not offered sufficient remedies for the anticompetitive conduct identified by the jury. The proposed injunction aims to force a structural change in how Medtronic markets its advanced bipolar energy devices. This legal action forces operators to consider how future antitrust rulings may limit long-standing sales strategies.
Timeline
October 5, 2026: Applied Medical Resources filed the reply.
Market Landscape
This filing follows the pattern set by the Ethicon antitrust relief matter by establishing a long-term compliance baseline for competitors. It marks a push to align current industry standards with historic precedents for competitive fairness.
Owners and operators should monitor this case as a signal for potential changes in how manufacturers contract and bundle surgical equipment. It is advisable to consult with counsel to evaluate if your current procurement agreements align with evolving antitrust standards.
The takeaway
This case illustrates the legal scrutiny applied to aggressive sales tactics in the medical device sector. Operators should track the final ruling to identify what specific marketing or bundling practices are now deemed prohibited.
Further reading
Read more about industry standards in the Healthcare section.
Source note: This article includes information reported by Mlex.
Live Poll
Should courts impose stricter penalties on companies found to have engaged in anticompetitive business practices?
